APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Combination Vaccine and Multivalent Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Veterinary Combination Vaccine and Multivalent Vaccine Market Outlook and Growth Opportunities 2026

Report ID 174046020427 December 2025209 pages

Choose your research edition.

Industry ResearchVeterinary Combination Vaccine and Multivalent Vaccine Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Combination Vaccine and Multivalent Vaccine Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Veterinary Combination Vaccine and Multivalent Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Combination Vaccine and Multivalent Vaccine Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Combination Vaccine and Multivalent Vaccine Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Veterinary Combination Vaccine and Multivalent Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Veterinary Combination Vaccine and Multivalent Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Combination Vaccine and Multivalent Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Combination Vaccine and Multivalent Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Veterinary Combination Vaccine and Multivalent Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Veterinary Combination Vaccine and Multivalent Vaccine market include Bioveta, Boehringer Ingelheim, Ceva Animal Health, Elanco, HIPRA, Merck Animal Health, Virbac, Zoetis and Aichong Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Veterinary Combination Vaccine and Multivalent Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Combination Vaccine and Multivalent Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Combination Vaccine and Multivalent Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary Combination Vaccine and Multivalent Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary Combination Vaccine and Multivalent Vaccine Segment by Company

Bioveta

Boehringer Ingelheim

Ceva Animal Health

Elanco

HIPRA

Merck Animal Health

Virbac

Zoetis

Aichong Group

Bolaideli Biotechnology

Harbin Pharmaceutical Group

Huapai Biotechnology

Keqian Biology

Pulike Biological

Ringpu Bio-technology

Yian Biological

China Animal Husbandy Industry

Veterinary Combination Vaccine and Multivalent Vaccine Segment by Type

Combination Vaccine

Multivalent Vaccine

Veterinary Combination Vaccine and Multivalent Vaccine Segment by Application

Domestic Animal

Poultry

Veterinary Combination Vaccine and Multivalent Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Veterinary Combination Vaccine and Multivalent Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Veterinary Combination Vaccine and Multivalent Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Veterinary Combination Vaccine and Multivalent Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Veterinary Combination Vaccine and Multivalent Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Combination Vaccine and Multivalent Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Combination Vaccine and Multivalent Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Combination Vaccine and Multivalent Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary Combination Vaccine and Multivalent Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Combination Vaccine and Multivalent Vaccine industry.

Chapter 3: Detailed analysis of Veterinary Combination Vaccine and Multivalent Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Veterinary Combination Vaccine and Multivalent Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Veterinary Combination Vaccine and Multivalent Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Veterinary Combination Vaccine and Multivalent Vaccine Industry Trends Table 2. Veterinary Combination Vaccine and Multivalent Vaccine Industry Drivers Table 3. Veterinary Combination Vaccine and Multivalent Vaccine Industry Opportunities and Challenges Table 4. Veterinary Combination Vaccine and Multivalent Vaccine Industry Restraints Table 5. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue Share by Company (2021-2026) Table 7. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume by Company (Units) & (2021-2026) Table 8. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Veterinary Combination Vaccine and Multivalent Vaccine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Veterinary Combination Vaccine and Multivalent Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Veterinary Combination Vaccine and Multivalent Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Veterinary Combination Vaccine and Multivalent Vaccine Company, Product Type & Application Table 13. Global Veterinary Combination Vaccine and Multivalent Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Veterinary Combination Vaccine and Multivalent Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Combination Vaccine Table 18. Significant Companies of Multivalent Vaccine Table 19. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume by Type (2021-2026) & (Units) Table 21. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume by Type (2027-2032) & (Units) Table 22. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Domestic Animal Table 30. Significant Companies of Poultry Table 31. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 32. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume by Application (2021-2026) & (Units) Table 33. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume by Application (2027-2032) & (Units) Table 34. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume Share by Application (2021-2026) Table 35. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume Share by Application (2027-2032) Table 36. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application (2021-2026) Table 40. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application (2027-2032) Table 41. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 42. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Region (2021-2026) & (Units) Table 43. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Region (2027-2032) & (Units) Table 45. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Region (2027-2032) Table 46. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Region (2021-2026) Table 49. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Region (2027-2032) Table 51. Global Veterinary Combination Vaccine and Multivalent Vaccine Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Veterinary Combination Vaccine and Multivalent Vaccine Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 54. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2021-2026) & (Units) Table 56. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Country (2021-2026) Table 57. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2027-2032) & (Units) Table 58. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Country (2027-2032) Table 59. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Market Share by Country (2021-2026) Table 61. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Market Share by Country (2027-2032) Table 63. Bioveta Company Information Table 64. Bioveta Business Overview Table 65. Bioveta Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Bioveta Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 67. Bioveta Recent Development Table 68. Boehringer Ingelheim Company Information Table 69. Boehringer Ingelheim Business Overview Table 70. Boehringer Ingelheim Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Boehringer Ingelheim Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 72. Boehringer Ingelheim Recent Development Table 73. Ceva Animal Health Company Information Table 74. Ceva Animal Health Business Overview Table 75. Ceva Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Ceva Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 77. Ceva Animal Health Recent Development Table 78. Elanco Company Information Table 79. Elanco Business Overview Table 80. Elanco Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Elanco Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 82. Elanco Recent Development Table 83. HIPRA Company Information Table 84. HIPRA Business Overview Table 85. HIPRA Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. HIPRA Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 87. HIPRA Recent Development Table 88. Merck Animal Health Company Information Table 89. Merck Animal Health Business Overview Table 90. Merck Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Merck Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 92. Merck Animal Health Recent Development Table 93. Virbac Company Information Table 94. Virbac Business Overview Table 95. Virbac Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Virbac Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 97. Virbac Recent Development Table 98. Zoetis Company Information Table 99. Zoetis Business Overview Table 100. Zoetis Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Zoetis Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 102. Zoetis Recent Development Table 103. Aichong Group Company Information Table 104. Aichong Group Business Overview Table 105. Aichong Group Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Aichong Group Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 107. Aichong Group Recent Development Table 108. Bolaideli Biotechnology Company Information Table 109. Bolaideli Biotechnology Business Overview Table 110. Bolaideli Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Bolaideli Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 112. Bolaideli Biotechnology Recent Development Table 113. Harbin Pharmaceutical Group Company Information Table 114. Harbin Pharmaceutical Group Business Overview Table 115. Harbin Pharmaceutical Group Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Harbin Pharmaceutical Group Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 117. Harbin Pharmaceutical Group Recent Development Table 118. Huapai Biotechnology Company Information Table 119. Huapai Biotechnology Business Overview Table 120. Huapai Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Huapai Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 122. Huapai Biotechnology Recent Development Table 123. Keqian Biology Company Information Table 124. Keqian Biology Business Overview Table 125. Keqian Biology Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Keqian Biology Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 127. Keqian Biology Recent Development Table 128. Pulike Biological Company Information Table 129. Pulike Biological Business Overview Table 130. Pulike Biological Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Pulike Biological Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 132. Pulike Biological Recent Development Table 133. Ringpu Bio-technology Company Information Table 134. Ringpu Bio-technology Business Overview Table 135. Ringpu Bio-technology Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Ringpu Bio-technology Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 137. Ringpu Bio-technology Recent Development Table 138. Yian Biological Company Information Table 139. Yian Biological Business Overview Table 140. Yian Biological Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Yian Biological Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 142. Yian Biological Recent Development Table 143. China Animal Husbandy Industry Company Information Table 144. China Animal Husbandy Industry Business Overview Table 145. China Animal Husbandy Industry Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. China Animal Husbandy Industry Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 147. China Animal Husbandy Industry Recent Development Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Veterinary Combination Vaccine and Multivalent Vaccine Distributors List Table 151. Veterinary Combination Vaccine and Multivalent Vaccine Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Veterinary Combination Vaccine and Multivalent Vaccine Product Image Figure 2. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales (2021-2032) & (Units) Figure 5. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Veterinary Combination Vaccine and Multivalent Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Combination Vaccine Image Figure 10. Multivalent Vaccine Image Figure 11. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type (2021-2032) Figure 17. Domestic Animal Image Figure 18. Poultry Image Figure 19. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 20. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume Share by Application (2021-2032) Figure 22. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application (2021-2032) Figure 25. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 26. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Veterinary Combination Vaccine and Multivalent Vaccine Sales Value (2021-2032) & (US$ Million) Figure 30. North America Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Veterinary Combination Vaccine and Multivalent Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Veterinary Combination Vaccine and Multivalent Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. South America Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Veterinary Combination Vaccine and Multivalent Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Veterinary Combination Vaccine and Multivalent Vaccine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Veterinary Combination Vaccine and Multivalent Vaccine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Combination Vaccine
  • Multivalent Vaccine
Applications
  • Domestic Animal
  • Poultry
Companies covered
  • Bioveta
  • Boehringer Ingelheim
  • Ceva Animal Health
  • Elanco
  • HIPRA
  • Merck Animal Health
  • Virbac
  • Zoetis
  • Aichong Group
  • Bolaideli Biotechnology
  • Harbin Pharmaceutical Group
  • Huapai Biotechnology
  • Keqian Biology
  • Pulike Biological
  • Ringpu Bio-technology
  • Yian Biological
  • China Animal Husbandy Industry

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Veterinary Combination Vaccine and Multivalent Vaccine Market Dynamics
  1. 2.1 Veterinary Combination Vaccine and Multivalent Vaccine Industry Trends
  2. 2.2 Veterinary Combination Vaccine and Multivalent Vaccine Industry Drivers
  3. 2.3 Veterinary Combination Vaccine and Multivalent Vaccine Industry Opportunities and Challenges
  4. 2.4 Veterinary Combination Vaccine and Multivalent Vaccine Industry Restraints
3 Veterinary Combination Vaccine and Multivalent Vaccine Market by Company
  1. 3.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Veterinary Combination Vaccine and Multivalent Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Veterinary Combination Vaccine and Multivalent Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Veterinary Combination Vaccine and Multivalent Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Veterinary Combination Vaccine and Multivalent Vaccine Company Product Type and Application
  8. 3.8 Global Veterinary Combination Vaccine and Multivalent Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Veterinary Combination Vaccine and Multivalent Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Veterinary Combination Vaccine and Multivalent Vaccine Market by Type
  1. 4.1 Veterinary Combination Vaccine and Multivalent Vaccine Type Introduction
  2. 4.1.1 Combination Vaccine
  3. 4.1.2 Multivalent Vaccine
  4. 4.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume by Type
  5. 4.2.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Type
  9. 4.3.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type (2021-2032)
5 Veterinary Combination Vaccine and Multivalent Vaccine Market by Application
  1. 5.1 Veterinary Combination Vaccine and Multivalent Vaccine Application Introduction
  2. 5.1.1 Domestic Animal
  3. 5.1.2 Poultry
  4. 5.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume by Application
  5. 5.2.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Application
  9. 5.3.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application (2021-2032)
6 Veterinary Combination Vaccine and Multivalent Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Veterinary Combination Vaccine and Multivalent Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Veterinary Combination Vaccine and Multivalent Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Veterinary Combination Vaccine and Multivalent Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Veterinary Combination Vaccine and Multivalent Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Veterinary Combination Vaccine and Multivalent Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Country, 2025 VS 2032
7 Veterinary Combination Vaccine and Multivalent Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Veterinary Combination Vaccine and Multivalent Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bioveta
  2. 8.1.1 Bioveta Company Information
  3. 8.1.2 Bioveta Business Overview
  4. 8.1.3 Bioveta Veterinary Combination Vaccine and Multivalent Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bioveta Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  6. 8.1.5 Bioveta Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim Veterinary Combination Vaccine and Multivalent Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 Ceva Animal Health
  14. 8.3.1 Ceva Animal Health Company Information
  15. 8.3.2 Ceva Animal Health Business Overview
  16. 8.3.3 Ceva Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Ceva Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  18. 8.3.5 Ceva Animal Health Recent Developments
  19. 8.4 Elanco
  20. 8.4.1 Elanco Company Information
  21. 8.4.2 Elanco Business Overview
  22. 8.4.3 Elanco Veterinary Combination Vaccine and Multivalent Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Elanco Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  24. 8.4.5 Elanco Recent Developments
  25. 8.5 HIPRA
  26. 8.5.1 HIPRA Company Information
  27. 8.5.2 HIPRA Business Overview
  28. 8.5.3 HIPRA Veterinary Combination Vaccine and Multivalent Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 HIPRA Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  30. 8.5.5 HIPRA Recent Developments
  31. 8.6 Merck Animal Health
  32. 8.6.1 Merck Animal Health Company Information
  33. 8.6.2 Merck Animal Health Business Overview
  34. 8.6.3 Merck Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Merck Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  36. 8.6.5 Merck Animal Health Recent Developments
  37. 8.7 Virbac
  38. 8.7.1 Virbac Company Information
  39. 8.7.2 Virbac Business Overview
  40. 8.7.3 Virbac Veterinary Combination Vaccine and Multivalent Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Virbac Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  42. 8.7.5 Virbac Recent Developments
  43. 8.8 Zoetis
  44. 8.8.1 Zoetis Company Information
  45. 8.8.2 Zoetis Business Overview
  46. 8.8.3 Zoetis Veterinary Combination Vaccine and Multivalent Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Zoetis Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  48. 8.8.5 Zoetis Recent Developments
  49. 8.9 Aichong Group
  50. 8.9.1 Aichong Group Company Information
  51. 8.9.2 Aichong Group Business Overview
  52. 8.9.3 Aichong Group Veterinary Combination Vaccine and Multivalent Vaccine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Aichong Group Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  54. 8.9.5 Aichong Group Recent Developments
  55. 8.10 Bolaideli Biotechnology
  56. 8.10.1 Bolaideli Biotechnology Company Information
  57. 8.10.2 Bolaideli Biotechnology Business Overview
  58. 8.10.3 Bolaideli Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Bolaideli Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  60. 8.10.5 Bolaideli Biotechnology Recent Developments
  61. 8.11 Harbin Pharmaceutical Group
  62. 8.11.1 Harbin Pharmaceutical Group Company Information
  63. 8.11.2 Harbin Pharmaceutical Group Business Overview
  64. 8.11.3 Harbin Pharmaceutical Group Veterinary Combination Vaccine and Multivalent Vaccine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Harbin Pharmaceutical Group Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  66. 8.11.5 Harbin Pharmaceutical Group Recent Developments
  67. 8.12 Huapai Biotechnology
  68. 8.12.1 Huapai Biotechnology Company Information
  69. 8.12.2 Huapai Biotechnology Business Overview
  70. 8.12.3 Huapai Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Huapai Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  72. 8.12.5 Huapai Biotechnology Recent Developments
  73. 8.13 Keqian Biology
  74. 8.13.1 Keqian Biology Company Information
  75. 8.13.2 Keqian Biology Business Overview
  76. 8.13.3 Keqian Biology Veterinary Combination Vaccine and Multivalent Vaccine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Keqian Biology Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  78. 8.13.5 Keqian Biology Recent Developments
  79. 8.14 Pulike Biological
  80. 8.14.1 Pulike Biological Company Information
  81. 8.14.2 Pulike Biological Business Overview
  82. 8.14.3 Pulike Biological Veterinary Combination Vaccine and Multivalent Vaccine Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Pulike Biological Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  84. 8.14.5 Pulike Biological Recent Developments
  85. 8.15 Ringpu Bio-technology
  86. 8.15.1 Ringpu Bio-technology Company Information
  87. 8.15.2 Ringpu Bio-technology Business Overview
  88. 8.15.3 Ringpu Bio-technology Veterinary Combination Vaccine and Multivalent Vaccine Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Ringpu Bio-technology Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  90. 8.15.5 Ringpu Bio-technology Recent Developments
  91. 8.16 Yian Biological
  92. 8.16.1 Yian Biological Company Information
  93. 8.16.2 Yian Biological Business Overview
  94. 8.16.3 Yian Biological Veterinary Combination Vaccine and Multivalent Vaccine Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Yian Biological Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  96. 8.16.5 Yian Biological Recent Developments
  97. 8.17 China Animal Husbandy Industry
  98. 8.17.1 China Animal Husbandy Industry Company Information
  99. 8.17.2 China Animal Husbandy Industry Business Overview
  100. 8.17.3 China Animal Husbandy Industry Veterinary Combination Vaccine and Multivalent Vaccine Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 China Animal Husbandy Industry Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  102. 8.17.5 China Animal Husbandy Industry Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Veterinary Combination Vaccine and Multivalent Vaccine Value Chain Analysis
  2. 9.1.1 Veterinary Combination Vaccine and Multivalent Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Veterinary Combination Vaccine and Multivalent Vaccine Sales Mode & Process
  6. 9.2 Veterinary Combination Vaccine and Multivalent Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Veterinary Combination Vaccine and Multivalent Vaccine Distributors
  9. 9.2.3 Veterinary Combination Vaccine and Multivalent Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst